FI953830A - Screening av graviditetsavvikelser före födseln - Google Patents
Screening av graviditetsavvikelser före födseln Download PDFInfo
- Publication number
- FI953830A FI953830A FI953830A FI953830A FI953830A FI 953830 A FI953830 A FI 953830A FI 953830 A FI953830 A FI 953830A FI 953830 A FI953830 A FI 953830A FI 953830 A FI953830 A FI 953830A
- Authority
- FI
- Finland
- Prior art keywords
- marker
- level
- screening
- woman
- pregnant
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
- G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Steroid Compounds (AREA)
- Fire Alarms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9416415 | 1994-08-13 | ||
GB9416415A GB9416415D0 (en) | 1994-08-13 | 1994-08-13 | Antenatel screening for pregnacy abnormalities |
Publications (3)
Publication Number | Publication Date |
---|---|
FI953830A0 FI953830A0 (sv) | 1995-08-11 |
FI953830A true FI953830A (sv) | 1996-02-14 |
FI119451B FI119451B (sv) | 2008-11-14 |
Family
ID=10759858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI953830A FI119451B (sv) | 1994-08-13 | 1995-08-11 | Screening av graviditetsavvikelser före födseln |
Country Status (10)
Country | Link |
---|---|
US (1) | US6022695A (sv) |
EP (1) | EP0701131B1 (sv) |
JP (1) | JP3626251B2 (sv) |
KR (1) | KR100389988B1 (sv) |
AT (1) | ATE213334T1 (sv) |
AU (1) | AU698204B2 (sv) |
CA (1) | CA2155919C (sv) |
DE (1) | DE69525400T2 (sv) |
FI (1) | FI119451B (sv) |
GB (1) | GB9416415D0 (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9606261D0 (en) * | 1996-03-25 | 1996-05-29 | Johnson & Johnson Clin Diag | Prenatal screening for fetal abnormalities |
GB9614615D0 (en) * | 1996-07-11 | 1996-09-04 | Isis Innovation | Diagnosis of pre-eclampsia |
US6620590B2 (en) | 1996-07-11 | 2003-09-16 | Isis Innovation Limited | Diagnosis of pre-eclampsia |
US20050131738A1 (en) * | 2002-05-15 | 2005-06-16 | Morris Tommy J. | System and method for handling medical information |
CA2486089C (en) | 2002-05-15 | 2013-12-17 | Tommy J. Morris | System and method for handling medical information |
US7315787B2 (en) * | 2003-10-07 | 2008-01-01 | Ntd Laboratories, Inc. | Multi-marker screening protocol for fetal abnormalities |
RU2373842C2 (ru) * | 2003-12-02 | 2009-11-27 | Шрага РОТТЕМ | Искусственный интеллект и устройство для диагностики, скрининга, профилактики и лечения состояний системы матери и плода |
US20070249531A1 (en) * | 2004-02-20 | 2007-10-25 | Aplagen Gmbh | Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility |
ATE538217T1 (de) * | 2007-07-02 | 2012-01-15 | Univ Edinburgh | Erkennung von ektopischen schwangerschaften |
US20100027571A1 (en) * | 2008-07-31 | 2010-02-04 | Murdoch Keith M | Stabilized near-infrared laser |
WO2011144999A1 (en) | 2010-05-17 | 2011-11-24 | Sandra Reznik | Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities |
CN116358954A (zh) * | 2023-02-22 | 2023-06-30 | 深圳市昭蓝生物科技有限公司 | 复合质控品及其制备方法和产前筛查试剂盒 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4874693A (en) * | 1986-10-10 | 1989-10-17 | Mark Bogart | Method for assessing placental dysfunction |
DE3882140T2 (de) * | 1987-07-09 | 1993-12-23 | 3I Research Exploit Ltd | Pränatales screening für downs-syndrom. |
GB8816714D0 (en) * | 1988-07-14 | 1988-08-17 | Univ Court Of University Of Gl | Switched reluctance motors |
EP0409956B2 (en) * | 1989-01-17 | 2004-07-21 | MACRI, James N. | Down syndrome screening method |
GB9224965D0 (en) * | 1992-11-28 | 1993-01-20 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
GB9410345D0 (en) * | 1994-05-24 | 1994-07-13 | Univ Oxford Brookes | Method of genetic testing |
US5716853A (en) * | 1995-07-07 | 1998-02-10 | Chiron Diagnostics Corporation | Prenatal down syndrome screening with assays specific for UGP |
-
1994
- 1994-08-13 GB GB9416415A patent/GB9416415D0/en active Pending
-
1995
- 1995-08-07 US US08/511,942 patent/US6022695A/en not_active Expired - Lifetime
- 1995-08-10 AU AU28487/95A patent/AU698204B2/en not_active Expired
- 1995-08-11 EP EP95305618A patent/EP0701131B1/en not_active Expired - Lifetime
- 1995-08-11 JP JP20583995A patent/JP3626251B2/ja not_active Expired - Fee Related
- 1995-08-11 AT AT95305618T patent/ATE213334T1/de not_active IP Right Cessation
- 1995-08-11 FI FI953830A patent/FI119451B/sv not_active IP Right Cessation
- 1995-08-11 DE DE69525400T patent/DE69525400T2/de not_active Expired - Lifetime
- 1995-08-11 CA CA002155919A patent/CA2155919C/en not_active Expired - Lifetime
- 1995-08-14 KR KR1019950024989A patent/KR100389988B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0701131B1 (en) | 2002-02-13 |
DE69525400D1 (de) | 2002-03-21 |
KR100389988B1 (ko) | 2003-12-06 |
FI953830A0 (sv) | 1995-08-11 |
AU2848795A (en) | 1996-02-29 |
DE69525400T2 (de) | 2002-07-18 |
CA2155919C (en) | 2007-06-05 |
US6022695A (en) | 2000-02-08 |
JP3626251B2 (ja) | 2005-03-02 |
AU698204B2 (en) | 1998-10-29 |
ATE213334T1 (de) | 2002-02-15 |
KR960008312A (ko) | 1996-03-22 |
FI119451B (sv) | 2008-11-14 |
EP0701131A2 (en) | 1996-03-13 |
JPH09113508A (ja) | 1997-05-02 |
EP0701131A3 (en) | 1996-05-29 |
CA2155919A1 (en) | 1996-02-14 |
GB9416415D0 (en) | 1994-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Biasio et al. | First‐trimester screening for Down syndrome using nuchal translucency measurement with free β‐hCG and PAPP‐A between 10 and 13 weeks of pregnancy—the combined test | |
FI953830A0 (sv) | Screening av graviditetsavvikelser före födseln | |
DK0627082T3 (da) | Antenatal screening for kromosomale abnormaliteter | |
PT923730E (pt) | Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada | |
Öney et al. | The value of the mean arterial blood pressure in the second trimester (MAP-2 value) as a predictor of pregnancy-induced hypertension and preeclampsia. A preliminary report | |
ATE227024T1 (de) | Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut | |
DE3882140D1 (en) | Praenatales screening fuer downs-syndrom. | |
Vollebergh et al. | The accuracy of ultrasonic measurement of fetal crown-rump length | |
SG52419A1 (en) | Antenatal screening for chromosomal abnormalities | |
GB9315230D0 (en) | Antenatal screening for chromosomal abnormalities | |
Zoppi et al. | Can fetal iliac bone measurement be used as a marker for Down's syndrome screening? | |
ATE240525T1 (de) | Pränatales testverfahren für down-syndrom | |
Haddad et al. | Severe uterine diastolic notch as a prognostic factor in preeclamptic women | |
Wenger et al. | First trimester maternal serum α‐fetoprotein screening for Down syndrome and other aneuploidies | |
AHMED et al. | Determination of the stage of gestation by the assay of chorionic gonadotrophin and Schwangerschaftsprotein 1 | |
Agree | TESTING FOR PREGNANCY | |
Easterling et al. | Maternal weight, hemodynamics, and preeclampsia | |
Preboth | Fetal screening in the first trimester | |
Phillips et al. | Abnormal maternal serum screening results and ultrasonography: Part II: Screen-positive for chromosome abnormalities |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: ORTHO-CLINICAL DIAGNOSTICS, INC. Free format text: ORTHO-CLINICAL DIAGNOSTICS, INC. |
|
FG | Patent granted |
Ref document number: 119451 Country of ref document: FI |
|
MA | Patent expired |